DPP4 and type 2 diabetes mellitus: Tanaka et al. pointed out that T2DM patients with or without previous CV events were recruited in the PROLOGUE study [58], while other studies investigating the effects of DPP-4 inhibitors only recruited T2DM patients without events [24, 25].